Stay updated on clinical development milestones and clinical trial approvals we are proud to help our sponsors achieve
The study aims to evaluate the efficacy, safety and individual tolerance of treatment with a drug in patients with seborrheic dermatitis of the scalp.
More than 250 patients have been enrolled in a study a month and a half prior to the initially set deadline. The total duration of enrollment comprised 4 months.
* - Required fields